Our results showed that Dp3-Sam treatment suppressed the ACC, FASN, SREBP-1 C, and HMGCR expression in the liver tissue of HFD rats, indicating that lipid metabolism disorders could be improved by Dp3-Sam intervention. Here, FASN is linked to Disorder of lipid metabolism.